Cargando…
The Successful Vaccination of an IVIgG Naive CVID Patient with an mRNA COVID-19 Vaccine
INTRODUCTION: Different subtypes of vaccines have been developed to help protect populations from COVID-19. Currently, three vaccines have been authorized by the United States Food and Drug Administration for emergency use to combat the COVID-19 pandemic. With COVID-19 vaccination rates increasing,...
Autores principales: | Jalil, Maaz, Abraham, John M., Hostoffer, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514739/ https://www.ncbi.nlm.nih.gov/pubmed/34659871 http://dx.doi.org/10.1177/21526567211049744 |
Ejemplares similares
-
Persistent Immune Activation in CVID and the Role of IVIg in Its Suppression
por: Paquin-Proulx, Dominic, et al.
Publicado: (2014) -
Successful Anti-SARS-CoV-2 Spike Protein Antibody Response to Vaccination in MAGT1 Deficiency
por: Jalil, Maaz, et al.
Publicado: (2021) -
CIDP: Analysis of Immunomarkers During COVID-19 mRNA-Vaccination and IVIg-Immunomodulation: An Exploratory Study
por: Svačina, Martin K. R., et al.
Publicado: (2023) -
Immune Responses Of CVID Patients To COVID-19 Vaccines
por: Xavier de Medeiros, Giuliana, et al.
Publicado: (2023) -
IVIg Immune Reconstitution Treatment Alleviates the State of Persistent Immune Activation and Suppressed CD4 T Cell Counts in CVID
por: Paquin-Proulx, Dominic, et al.
Publicado: (2013)